Download PDF

1. Company Snapshot

1.a. Company Description

SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases; and in home medical assistance and related medical equipment in Italy and internationally.The company offers technical and medical gases, including oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use.It also provides home oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids.


In addition, it provides medical devices; training services; InfoHealth SOLution, a web platform that allows to control plans, coordinate, and manage the activities; electromedical equipment services; hospital hygiene and environmental monitoring services; and ambulance management services.Further, it designs, constructs, and manages bio banks; distribution of medical and technical gases; produces and sells hydroelectric power; offers pre-and post-natal diagnostic screening services; produces and sells diagnostic systems; researches, develops, and markets products for research, diagnosis and clinical application in the hospital, environmental, veterinary and food sectors; and bioshipping services, as well as provides transfer, storage, and handling services of biological samples.Its products are used in the chemical, electronics, steel, metal, and food industries, as well as in environmental protection, and research and healthcare sectors.


The company was founded in 1927 and is headquartered in Monza, Italy.SOL S.p.A. is a subsidiary of Gas and Technologies World BV.

Show Full description

1.b. Last Insights on SOL

Have nothing to say about that one ...

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

SOL (BIT:SOL) Reports Strong Half-Year Earnings With 12% Sales Growth

Sep -12

Source:

Card image cap

Societe Generale: shares & voting rights as of 31 August 2025

Sep -09

Source:

Card image cap

Assessing Acciona (BME:ANA)'s Valuation After Recent Subtle Moves

Sep -09

Source:

Card image cap

Deutsche Bank (XTRA:DBK): Assessing Valuation After a Period of Quiet Share Price Momentum

Sep -09

Source:

Card image cap

Is Vaisala (HLSE:VAIAS) Undervalued? A Fresh Look at Its Current Valuation

Sep -09

Source:

Card image cap

Has Evotec’s 29.5% Price Drop Created a New Opportunity for 2025?

Sep -09

Source:

Card image cap

Repsol (BME:REP): Evaluating Whether Recent Momentum Reflects Fair Value or Hidden Growth Potential

Sep -09

Source:

Card image cap

Bayer (XTRA:BAYN): Is Recent Momentum Signaling a Shift in Valuation?

Sep -09

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (7.96%)

6. Segments

Technical Gasses

Expected Growth: 7%

SOL S.p.A.'s 7% growth in Technical Gases is driven by increasing demand from industrial manufacturing, particularly in the automotive and aerospace sectors. Additionally, growing adoption of clean energy technologies, such as hydrogen fuel cells, and rising use of medical gases in healthcare facilities also contribute to this growth.

Home Care

Expected Growth: 9%

SOL S.p.A.'s Home Care segment growth of 9% is driven by increasing demand for eco-friendly and sustainable cleaning products, expansion into emerging markets, and strategic partnerships with key retailers. Additionally, the company's focus on product innovation, digital marketing, and competitive pricing strategies have contributed to its growth momentum.

7. Detailed Products

Industrial Gases

SOL S.p.A. offers a wide range of industrial gases, including oxygen, nitrogen, argon, and carbon dioxide, used in various industries such as manufacturing, healthcare, and food processing.

Medical Gases

SOL S.p.A. provides medical gases, including oxygen, nitrous oxide, and medical air, used in hospitals, clinics, and medical facilities.

Specialty Gases

SOL S.p.A. offers specialty gases, including high-purity gases, calibration gases, and rare gases, used in industries such as electronics, pharmaceuticals, and research.

Cryogenic Gases

SOL S.p.A. provides cryogenic gases, including liquid nitrogen, liquid oxygen, and liquid argon, used in industries such as energy, aerospace, and healthcare.

Gas Mixtures

SOL S.p.A. offers custom gas mixtures, including calibration gases, laser gases, and specialty gas blends, used in industries such as manufacturing, healthcare, and research.

Equipment and Accessories

SOL S.p.A. provides equipment and accessories, including gas cylinders, regulators, and valves, used in industries such as manufacturing, healthcare, and research.

8. SOL S.p.A.'s Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for SOL S.p.A. is medium due to the presence of alternative energy sources and the increasing adoption of renewable energy.

Bargaining Power Of Customers

The bargaining power of customers for SOL S.p.A. is low due to the company's strong brand reputation and the lack of switching options for customers.

Bargaining Power Of Suppliers

The bargaining power of suppliers for SOL S.p.A. is medium due to the presence of multiple suppliers and the company's dependence on a few key suppliers.

Threat Of New Entrants

The threat of new entrants for SOL S.p.A. is high due to the low barriers to entry and the increasing demand for renewable energy.

Intensity Of Rivalry

The intensity of rivalry for SOL S.p.A. is high due to the presence of several established players and the increasing competition in the renewable energy market.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 37.91%
Debt Cost 3.95%
Equity Weight 62.09%
Equity Cost 6.46%
WACC 5.51%
Leverage 61.05%

11. Quality Control: SOL S.p.A. passed 5 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Buzzi Unicem

A-Score: 6.1/10

Value: 6.1

Growth: 7.3

Quality: 7.2

Yield: 3.8

Momentum: 8.0

Volatility: 4.3

1-Year Total Return ->

View Full Report
Stock-Card
Kemira

A-Score: 5.9/10

Value: 6.5

Growth: 6.0

Quality: 6.0

Yield: 6.9

Momentum: 2.5

Volatility: 7.7

1-Year Total Return ->

View Full Report
Stock-Card
SOL

A-Score: 5.3/10

Value: 2.2

Growth: 7.3

Quality: 4.9

Yield: 0.6

Momentum: 9.0

Volatility: 7.7

1-Year Total Return ->

View Full Report
Stock-Card
Dottikon Es Holding

A-Score: 4.9/10

Value: 2.5

Growth: 8.6

Quality: 7.0

Yield: 0.0

Momentum: 6.5

Volatility: 4.7

1-Year Total Return ->

View Full Report
Stock-Card
Solvay

A-Score: 4.7/10

Value: 6.0

Growth: 2.1

Quality: 3.4

Yield: 10.0

Momentum: 1.0

Volatility: 5.7

1-Year Total Return ->

View Full Report
Stock-Card
Bachem

A-Score: 4.1/10

Value: 3.3

Growth: 6.8

Quality: 6.4

Yield: 3.8

Momentum: 2.5

Volatility: 1.7

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

49.2$

Current Price

49.2$

Potential

-0.00%

Expected Cash-Flows